<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font28">the </span>
   <span class="font18">for </span>
   <span class="font18">children </span>
   <span class="font18">with </span>
   <span class="font17">influenza </span>
   <span class="font17">were </span>
   <span class="font16">baloxavir </span>
   <span class="font16">was </span>
   <span class="font14">The </span>
   <span class="font14">{background </span>
   <span class="font13">oseltamivir </span>
   <span class="font13">;:â€". </span>
   <span class="font13">treatment </span>
   <span class="font12">AEs </span>
   <span class="font12">from </span>
   <span class="font12">margin </span>
   <span class="font12">{border-style </span>
   <span class="font12">px;} </span>
   <span class="font12">virus </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">between </span>
   <span class="font12">both </span>
   <span class="font12">are </span>
   <span class="font12">baseline </span>
   <span class="font12">similar </span>
   <span class="font11">(.%) </span>
   <span class="font11">most </span>
   <span class="font11">respiratory </span>
   <span class="font11">study </span>
   <span class="font11">efficacy </span>
   <span class="font11">that </span>
   <span class="font11">viral </span>
   <span class="font11">acute </span>
   <span class="font11">groups </span>
   <span class="font11">had </span>
   <span class="font11">oral </span>
   <span class="font11">this </span>
   <span class="font11">time </span>
   <span class="font11">years </span>
   <span class="font11">day </span>
   <span class="font11">hours </span>
   <span class="font11">single </span>
   <span class="font11">safety </span>
   <span class="font11">symptoms </span>
   <span class="font11">Baloxavir </span>
   <span class="font11">dose </span>
   <span class="font11">infections </span>
   <span class="font11">patients </span>
   <span class="font11">who </span>
   <span class="font11">any </span>
   <span class="font11">during </span>
   <span class="font11">group </span>
   <span class="font11">groups, </span>
   <span class="font11">oseltamivir. </span>
   <span class="font11">phase </span>
   <span class="font11">population </span>
   <span class="font11">px; </span>
   <span class="font11">resistance </span>
   <span class="font11">{font-family </span>
   <span class="font10">ITTi </span>
   <span class="font10">PA/IX </span>
   <span class="font10">This </span>
   <span class="font10">all </span>
   <span class="font10">antiviral </span>
   <span class="font10">been </span>
   <span class="font10">clinical </span>
   <span class="font10">font-size </span>
   <span class="font10">group. </span>
   <span class="font10">has </span>
   <span class="font10">incidence </span>
   <span class="font10">low </span>
   <span class="font10">observed </span>
   <span class="font10">old </span>
   <span class="font10">otitis </span>
   <span class="font10">study. </span>
   <span class="font10">there </span>
   <span class="font10">those </span>
   <span class="font10">trial </span>
   <span class="font10">â€"&amp;lt; </span>
   <span class="font10">Children </span>
   <span class="font10">Infect </span>
   <span class="font10">TTASS </span>
   <span class="font10">after </span>
   <span class="font10">children. </span>
   <span class="font10">compared </span>
   <span class="font10">double; </span>
   <span class="font10">have </span>
   <span class="font10">infectious </span>
   <span class="font10">marboxil </span>
   <span class="font10">media </span>
   <span class="font10">median </span>
   <span class="font10">received </span>
   <span class="font10">reported </span>
   <span class="font10">results </span>
   <span class="font10">than </span>
   <span class="font10">these </span>
   <span class="font10">(.â€".) </span>
   <span class="font10">.â€".) </span>
   <span class="font10">CI: </span>
   <span class="font10">Clin </span>
   <span class="font10">Dis. </span>
   <span class="font10">Ltd. </span>
   <span class="font10">Table </span>
   <span class="font10">United </span>
   <span class="font10">active </span>
   <span class="font10">based </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">chain </span>
   <span class="font10">coinfection </span>
   <span class="font10">coinfections </span>
   <span class="font10">common </span>
   <span class="font10">complications </span>
   <span class="font10">considered </span>
   <span class="font10">each </span>
   <span class="font10">effective </span>
   <span class="font10">endonuclease </span>
   <span class="font10">endpoints </span>
   <span class="font10">healthy </span>
   <span class="font10">including </span>
   <span class="font10">infection </span>
   <span class="font10">influenza. </span>
   <span class="font10">otherwise </span>
   <span class="font10">polymerase </span>
   <span class="font10">rate </span>
   <span class="font10">reduced </span>
   <span class="font10">reduction </span>
   <span class="font10">requiring </span>
   <span class="font10">return </span>
   <span class="font10">reverse </span>
   <span class="font10">sample </span>
   <span class="font10">secondary </span>
   <span class="font10">severe </span>
   <span class="font10">severity </span>
   <span class="font10">signs </span>
   <span class="font10">solid; </span>
   <span class="font10">studies </span>
   <span class="font10">study, </span>
   <span class="font10">subtype </span>
   <span class="font10">swab </span>
   <span class="font10">titer </span>
   <span class="font10">versus </span>
   <span class="font10">virologic </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">.collab: </span>
   <span class="font10">All </span>
   <span class="font10">However, </span>
   <span class="font10">Roche </span>
   <span class="font10">Secondary </span>
   <span class="font10">alleviation </span>
   <span class="font10">also </span>
   <span class="font10">analyses </span>
   <span class="font10">antibiotics </span>
   <span class="font10">bacterial </span>
   <span class="font10">baloxavir, </span>
   <span class="font10">bold </span>
   <span class="font10">cap-dependent </span>
   <span class="font10">child </span>
   <span class="font10">collected </span>
   <span class="font10">completed </span>
   <span class="font10">comprised </span>
   <span class="font10">controlled </span>
   <span class="font10">courier; </span>
   <span class="font10">days </span>
   <span class="font10">duration </span>
   <span class="font10">em; </span>
   <span class="font10">followed </span>
   <span class="font10">following </span>
   <span class="font10">hours, </span>
   <span class="font10">included </span>
   <span class="font10">infected </span>
   <span class="font10">influenza-related </span>
   <span class="font10">inhibitor </span>
   <span class="font10">laboratory </span>
   <span class="font10">new </span>
   <span class="font10">not </span>
   <span class="font10">overall </span>
   <span class="font10">participants </span>
   <span class="font10">placebo </span>
   <span class="font10">previous </span>
   <span class="font10">previously </span>
   <span class="font10">provided </span>
   <span class="font10">pt;} </span>
   <span class="font10">randomized </span>
   <span class="font10">reaction </span>
   <span class="font10">related </span>
   <span class="font10">seasonal </span>
   <span class="font10">sequencing </span>
   <span class="font10">shown </span>
   <span class="font10">substitutions </span>
   <span class="font10">such </span>
   <span class="font10">use </span>
   <span class="font10">using </span>
   <span class="font10">variants </span>
   <span class="font10">viruses </span>
   <span class="font10">vs. </span>
   <span class="font10">which </span>
   <span class="font10">without </span>
   <span class="font10">â‰¥ </span>
   <span class="font10">â€‰mg </span>
  </p>
 </body>
</html>
